Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
STK-001 / Stoke Therap
NCT04740476: An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome	Enrolling by invitation	2	60	US	STK-001	Stoke Therapeutics, Inc	Dravet Syndrome	02/26	03/27
NCT04442295: An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome	Completed	1/2	62	US	STK-001 - Single Ascending Doses, STK-001 - Multiple Ascending Doses	Stoke Therapeutics, Inc	Dravet Syndrome	12/23	04/24